Isidro Ferrer Selected Research

Muscular Diseases (Myopathy)

11/2015	New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.
7/2015	New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations.
6/2006	Different early pathogenesis in myotilinopathy compared to primary desminopathy.
5/2004	Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis.
2/2004	Overexpression of semicarbazide-sensitive amine oxidase in human myopathies.
2/2004	Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy.
2/2004	A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin.
7/2003	Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isidro Ferrer Research Topics

Disease

82	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 12/2003
23	Dementia (Dementias) 01/2021 - 11/2004
21	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 07/2005
18	Parkinson Disease (Parkinson's Disease) 01/2021 - 11/2003
16	Amyloid Plaque 06/2022 - 02/2005
14	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2021 - 10/2006
12	Inflammation (Inflammations) 01/2021 - 09/2013
11	Tauopathies 06/2022 - 12/2003
10	Cognitive Dysfunction 01/2021 - 01/2010
10	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 12/2014
8	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 06/2009
8	Disease Progression 01/2021 - 10/2010
8	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2018 - 05/2008
8	Muscular Diseases (Myopathy) 11/2015 - 07/2003
7	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2021 - 10/2006
6	Gliosis 09/2017 - 12/2004
5	Memory Disorders (Memory Loss) 10/2021 - 04/2014
5	Neuroinflammatory Diseases 08/2021 - 01/2013
5	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 03/2010
5	Lewy Body Disease (Lewy Body Dementia) 01/2017 - 02/2005
5	Synucleinopathies 03/2016 - 12/2004
5	Pick Disease of the Brain (Pick's Disease) 01/2016 - 07/2005
5	Myofibrillar Myopathy 09/2012 - 07/2003
4	Sporadic Creutzfeldt-Jakob Disease 10/2018 - 10/2010
4	Neoplasms (Cancer) 12/2017 - 07/2005
4	Huntington Disease (Huntington's Disease) 09/2017 - 12/2003
4	Muscle Weakness 07/2015 - 02/2004
3	Schizophrenia (Dementia Praecox) 11/2021 - 08/2014
3	Infections 01/2021 - 10/2017
3	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 12/2014
3	Neuroblastoma 01/2012 - 12/2002
3	Inclusion Body Myositis 05/2004 - 07/2003
2	Proteostasis Deficiencies 01/2021 - 01/2016
2	Scrapie 01/2021 - 05/2020
2	Parkinsonian Disorders (Parkinsonism) 01/2021 - 01/2018
2	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 11/2020 - 04/2003
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020 - 03/2016
2	Demyelinating Diseases (Demyelinating Disease) 10/2018 - 07/2010
2	Multiple System Atrophy 10/2018 - 04/2007
2	Atrophy 09/2017 - 07/2003
2	Ischemia 01/2017 - 04/2003
2	Fatal Familial Insomnia 01/2017 - 01/2016
2	Mixed Dementias 01/2017 - 11/2015
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2016 - 02/2005
2	Seizures (Absence Seizure) 08/2015 - 09/2011

Drug/Important Bio-Agent (IBA)

44	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2003
26	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2004
12	Messenger RNA (mRNA)IBA 01/2021 - 11/2004
10	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2015
10	Prion ProteinsIBA 01/2021 - 10/2006
10	alpha-SynucleinIBA 01/2019 - 11/2004
9	Protein Isoforms (Isoforms)IBA 01/2020 - 11/2004
9	UbiquitinIBA 01/2019 - 12/2003
9	Amyloid beta-PeptidesIBA 09/2013 - 02/2005
8	Phosphotransferases (Kinase)IBA 11/2021 - 12/2003
8	Peptide Hydrolases (Proteases)FDA Link 10/2020 - 12/2004
7	Peptides (Polypeptides)IBA 01/2021 - 09/2006
7	EnzymesIBA 01/2021 - 04/2003
7	SynucleinsIBA 01/2021 - 12/2004
6	PrionsIBA 12/2021 - 12/2013
6	Protein AggregatesIBA 10/2018 - 05/2006
6	Codon (Codons)IBA 01/2017 - 11/2006
6	DesminIBA 09/2012 - 02/2004
5	LipidsIBA 01/2021 - 10/2012
5	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2020 - 03/2010
5	Methionine (L-Methionine)FDA Link 01/2018 - 11/2006
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 12/2003
4	Valine (L-Valine)FDA Link 01/2018 - 11/2006
3	CytokinesIBA 01/2021 - 07/2010
3	sarkosylIBA 01/2020 - 12/2003
3	Pharmaceutical PreparationsIBA 01/2020 - 05/2006
3	CalciumIBA 01/2019 - 09/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2003
3	Adenosine (Adenocard)FDA LinkGeneric 11/2018 - 12/2007
3	purineIBA 11/2018 - 01/2016
3	Glutamic Acid (Glutamate)FDA Link 01/2018 - 07/2005
3	IronIBA 01/2017 - 01/2010
3	AntibodiesIBA 10/2016 - 12/2003
3	ProteomeIBA 11/2015 - 01/2013
3	Flavin-Adenine Dinucleotide (FAD)IBA 04/2014 - 01/2012
2	RNA (Ribonucleic Acid)IBA 06/2022 - 01/2010
2	Aquaporins (Water Channels)IBA 11/2021 - 11/2006
2	Nerve Growth Factor (NGF)IBA 10/2021 - 12/2009
2	tau Proteins (tau Protein)IBA 05/2021 - 09/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 05/2020
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 11/2015
2	ElementsIBA 01/2021 - 08/2007
2	ChemokinesIBA 11/2020 - 07/2010
2	Nuclear Proteins (Protein, Nuclear)IBA 10/2020 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 11/2017
2	Amino Acids FDA Link 01/2019 - 12/2013
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 08/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2018 - 05/2013
2	Endopeptidase K (Proteinase K)IBA 10/2018 - 10/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 12/2014
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2017 - 01/2017
2	CannabinoidsIBA 10/2016 - 01/2015
2	CB2 Cannabinoid ReceptorIBA 01/2016 - 01/2013

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2006
2	Denervation 01/2019 - 07/2003